Global Exosome Diagnostics and Therapeutics Market Size, Status and Forecast 2024-2031

Report ID: 917552 | Published Date: Sep 2024 | No. of Page: 108 | Base Year: 2023 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Exosome Diagnostics and Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Instrument
        1.2.3 Reagent
        1.2.4 Software
    1.3 Market by Application
        1.3.1 Global Exosome Diagnostics and Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Diagnostic
        1.3.3 Therapeutic
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Exosome Diagnostics and Therapeutics Market Perspective (2016-2027)
    2.2 Exosome Diagnostics and Therapeutics Growth Trends by Regions
        2.2.1 Exosome Diagnostics and Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Exosome Diagnostics and Therapeutics Historic Market Share by Regions (2016-2021)
        2.2.3 Exosome Diagnostics and Therapeutics Forecasted Market Size by Regions (2022-2027)
    2.3 Exosome Diagnostics and Therapeutics Industry Dynamic
        2.3.1 Exosome Diagnostics and Therapeutics Market Trends
        2.3.2 Exosome Diagnostics and Therapeutics Market Drivers
        2.3.3 Exosome Diagnostics and Therapeutics Market Challenges
        2.3.4 Exosome Diagnostics and Therapeutics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Exosome Diagnostics and Therapeutics Players by Revenue
        3.1.1 Global Top Exosome Diagnostics and Therapeutics Players by Revenue (2016-2021)
        3.1.2 Global Exosome Diagnostics and Therapeutics Revenue Market Share by Players (2016-2021)
    3.2 Global Exosome Diagnostics and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Exosome Diagnostics and Therapeutics Revenue
    3.4 Global Exosome Diagnostics and Therapeutics Market Concentration Ratio
        3.4.1 Global Exosome Diagnostics and Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Exosome Diagnostics and Therapeutics Revenue in 2020
    3.5 Exosome Diagnostics and Therapeutics Key Players Head office and Area Served
    3.6 Key Players Exosome Diagnostics and Therapeutics Product Solution and Service
    3.7 Date of Enter into Exosome Diagnostics and Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Exosome Diagnostics and Therapeutics Breakdown Data by Type
    4.1 Global Exosome Diagnostics and Therapeutics Historic Market Size by Type (2016-2021)
    4.2 Global Exosome Diagnostics and Therapeutics Forecasted Market Size by Type (2022-2027)

5 Exosome Diagnostics and Therapeutics Breakdown Data by Application
    5.1 Global Exosome Diagnostics and Therapeutics Historic Market Size by Application (2016-2021)
    5.2 Global Exosome Diagnostics and Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Exosome Diagnostics and Therapeutics Market Size (2016-2027)
    6.2 North America Exosome Diagnostics and Therapeutics Market Size by Type
        6.2.1 North America Exosome Diagnostics and Therapeutics Market Size by Type (2016-2021)
        6.2.2 North America Exosome Diagnostics and Therapeutics Market Size by Type (2022-2027)
        6.2.3 North America Exosome Diagnostics and Therapeutics Market Size by Type (2016-2027)
    6.3 North America Exosome Diagnostics and Therapeutics Market Size by Application
        6.3.1 North America Exosome Diagnostics and Therapeutics Market Size by Application (2016-2021)
        6.3.2 North America Exosome Diagnostics and Therapeutics Market Size by Application (2022-2027)
        6.3.3 North America Exosome Diagnostics and Therapeutics Market Size by Application (2016-2027)
    6.4 North America Exosome Diagnostics and Therapeutics Market Size by Country
        6.4.1 North America Exosome Diagnostics and Therapeutics Market Size by Country (2016-2021)
        6.4.2 North America Exosome Diagnostics and Therapeutics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Exosome Diagnostics and Therapeutics Market Size (2016-2027)
    7.2 Europe Exosome Diagnostics and Therapeutics Market Size by Type
        7.2.1 Europe Exosome Diagnostics and Therapeutics Market Size by Type (2016-2021)
        7.2.2 Europe Exosome Diagnostics and Therapeutics Market Size by Type (2022-2027)
        7.2.3 Europe Exosome Diagnostics and Therapeutics Market Size by Type (2016-2027)
    7.3 Europe Exosome Diagnostics and Therapeutics Market Size by Application
        7.3.1 Europe Exosome Diagnostics and Therapeutics Market Size by Application (2016-2021)
        7.3.2 Europe Exosome Diagnostics and Therapeutics Market Size by Application (2022-2027)
        7.3.3 Europe Exosome Diagnostics and Therapeutics Market Size by Application (2016-2027)
    7.4 Europe Exosome Diagnostics and Therapeutics Market Size by Country
        7.4.1 Europe Exosome Diagnostics and Therapeutics Market Size by Country (2016-2021)
        7.4.2 Europe Exosome Diagnostics and Therapeutics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size (2016-2027)
    8.2 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Type (2016-2027)
    8.3 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Application (2016-2027)
    8.4 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Exosome Diagnostics and Therapeutics Market Size (2016-2027)
    9.2 Latin America Exosome Diagnostics and Therapeutics Market Size by Type
        9.2.1 Latin America Exosome Diagnostics and Therapeutics Market Size by Type (2016-2021)
        9.2.2 Latin America Exosome Diagnostics and Therapeutics Market Size by Type (2022-2027)
        9.2.3 Latin America Exosome Diagnostics and Therapeutics Market Size by Type (2016-2027)
    9.3 Latin America Exosome Diagnostics and Therapeutics Market Size by Application
        9.3.1 Latin America Exosome Diagnostics and Therapeutics Market Size by Application (2016-2021)
        9.3.2 Latin America Exosome Diagnostics and Therapeutics Market Size by Application (2022-2027)
        9.3.3 Latin America Exosome Diagnostics and Therapeutics Market Size by Application (2016-2027)
    9.4 Latin America Exosome Diagnostics and Therapeutics Market Size by Country
        9.4.1 Latin America Exosome Diagnostics and Therapeutics Market Size by Country (2016-2021)
        9.4.2 Latin America Exosome Diagnostics and Therapeutics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size (2016-2027)
    10.2 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Type (2016-2027)
    10.3 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Application (2016-2027)
    10.4 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Aethlon Medical(US)
        11.1.1 Aethlon Medical(US) Company Details
        11.1.2 Aethlon Medical(US) Business Overview
        11.1.3 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Introduction
        11.1.4 Aethlon Medical(US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021)
        11.1.5 Aethlon Medical(US) Recent Development
    11.2 Exosome Diagnostics(US)
        11.2.1 Exosome Diagnostics(US) Company Details
        11.2.2 Exosome Diagnostics(US) Business Overview
        11.2.3 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Introduction
        11.2.4 Exosome Diagnostics(US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021)
        11.2.5 Exosome Diagnostics(US) Recent Development
    11.3 NanoSomix Inc.(US)
        11.3.1 NanoSomix Inc.(US) Company Details
        11.3.2 NanoSomix Inc.(US) Business Overview
        11.3.3 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Introduction
        11.3.4 NanoSomix Inc.(US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021)
        11.3.5 NanoSomix Inc.(US) Recent Development
    11.4 Thermo Fisher Scientific (US)
        11.4.1 Thermo Fisher Scientific (US) Company Details
        11.4.2 Thermo Fisher Scientific (US) Business Overview
        11.4.3 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Introduction
        11.4.4 Thermo Fisher Scientific (US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021)
        11.4.5 Thermo Fisher Scientific (US) Recent Development
    11.5 Malvern Instruments (UK)
        11.5.1 Malvern Instruments (UK) Company Details
        11.5.2 Malvern Instruments (UK) Business Overview
        11.5.3 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Introduction
        11.5.4 Malvern Instruments (UK) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021)
        11.5.5 Malvern Instruments (UK) Recent Development
    11.6 System Biosciences(US)
        11.6.1 System Biosciences(US) Company Details
        11.6.2 System Biosciences(US) Business Overview
        11.6.3 System Biosciences(US) Exosome Diagnostics and Therapeutics Introduction
        11.6.4 System Biosciences(US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021)
        11.6.5 System Biosciences(US) Recent Development
    11.7 NX Pharmagen (US)
        11.7.1 NX Pharmagen (US) Company Details
        11.7.2 NX Pharmagen (US) Business Overview
        11.7.3 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Introduction
        11.7.4 NX Pharmagen (US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021)
        11.7.5 NX Pharmagen (US) Recent Development
    11.8 Sistemic Inc(UK)
        11.8.1 Sistemic Inc(UK) Company Details
        11.8.2 Sistemic Inc(UK) Business Overview
        11.8.3 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Introduction
        11.8.4 Sistemic Inc(UK) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021)
        11.8.5 Sistemic Inc(UK) Recent Development
    11.9 Capricor Therapeutics (US)
        11.9.1 Capricor Therapeutics (US) Company Details
        11.9.2 Capricor Therapeutics (US) Business Overview
        11.9.3 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Introduction
        11.9.4 Capricor Therapeutics (US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021)
        11.9.5 Capricor Therapeutics (US) Recent Development
    11.10 Exiqon A/S (Denmark)
        11.10.1 Exiqon A/S (Denmark) Company Details
        11.10.2 Exiqon A/S (Denmark) Business Overview
        11.10.3 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Introduction
        11.10.4 Exiqon A/S (Denmark) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021)
        11.10.5 Exiqon A/S (Denmark) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Exosome Diagnostics and Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Instrument
    Table 3. Key Players of Reagent
    Table 4. Key Players of Software
    Table 5. Global Exosome Diagnostics and Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Exosome Diagnostics and Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Exosome Diagnostics and Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Exosome Diagnostics and Therapeutics Market Share by Regions (2016-2021)
    Table 9. Global Exosome Diagnostics and Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Exosome Diagnostics and Therapeutics Market Share by Regions (2022-2027)
    Table 11. Exosome Diagnostics and Therapeutics Market Trends
    Table 12. Exosome Diagnostics and Therapeutics Market Drivers
    Table 13. Exosome Diagnostics and Therapeutics Market Challenges
    Table 14. Exosome Diagnostics and Therapeutics Market Restraints
    Table 15. Global Exosome Diagnostics and Therapeutics Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Exosome Diagnostics and Therapeutics Market Share by Players (2016-2021)
    Table 17. Global Top Exosome Diagnostics and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Exosome Diagnostics and Therapeutics as of 2020)
    Table 18. Ranking of Global Top Exosome Diagnostics and Therapeutics Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Exosome Diagnostics and Therapeutics Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Exosome Diagnostics and Therapeutics Product Solution and Service
    Table 22. Date of Enter into Exosome Diagnostics and Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Exosome Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Type (2016-2021)
    Table 26. Global Exosome Diagnostics and Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Exosome Diagnostics and Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Application (2016-2021)
    Table 30. Global Exosome Diagnostics and Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Exosome Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Exosome Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Exosome Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Exosome Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Exosome Diagnostics and Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Exosome Diagnostics and Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Exosome Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Exosome Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Exosome Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Exosome Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Exosome Diagnostics and Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Exosome Diagnostics and Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Exosome Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Exosome Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Exosome Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Exosome Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Exosome Diagnostics and Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Exosome Diagnostics and Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Aethlon Medical(US) Company Details
    Table 63. Aethlon Medical(US) Business Overview
    Table 64. Aethlon Medical(US) Exosome Diagnostics and Therapeutics Product
    Table 65. Aethlon Medical(US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
    Table 66. Aethlon Medical(US) Recent Development
    Table 67. Exosome Diagnostics(US) Company Details
    Table 68. Exosome Diagnostics(US) Business Overview
    Table 69. Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Product
    Table 70. Exosome Diagnostics(US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
    Table 71. Exosome Diagnostics(US) Recent Development
    Table 72. NanoSomix Inc.(US) Company Details
    Table 73. NanoSomix Inc.(US) Business Overview
    Table 74. NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Product
    Table 75. NanoSomix Inc.(US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
    Table 76. NanoSomix Inc.(US) Recent Development
    Table 77. Thermo Fisher Scientific (US) Company Details
    Table 78. Thermo Fisher Scientific (US) Business Overview
    Table 79. Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Product
    Table 80. Thermo Fisher Scientific (US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
    Table 81. Thermo Fisher Scientific (US) Recent Development
    Table 82. Malvern Instruments (UK) Company Details
    Table 83. Malvern Instruments (UK) Business Overview
    Table 84. Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Product
    Table 85. Malvern Instruments (UK) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
    Table 86. Malvern Instruments (UK) Recent Development
    Table 87. System Biosciences(US) Company Details
    Table 88. System Biosciences(US) Business Overview
    Table 89. System Biosciences(US) Exosome Diagnostics and Therapeutics Product
    Table 90. System Biosciences(US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
    Table 91. System Biosciences(US) Recent Development
    Table 92. NX Pharmagen (US) Company Details
    Table 93. NX Pharmagen (US) Business Overview
    Table 94. NX Pharmagen (US) Exosome Diagnostics and Therapeutics Product
    Table 95. NX Pharmagen (US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
    Table 96. NX Pharmagen (US) Recent Development
    Table 97. Sistemic Inc(UK) Company Details
    Table 98. Sistemic Inc(UK) Business Overview
    Table 99. Sistemic Inc(UK) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
    Table 100. Sistemic Inc(UK) Recent Development
    Table 101. Capricor Therapeutics (US) Company Details
    Table 102. Capricor Therapeutics (US) Business Overview
    Table 103. Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Product
    Table 104. Capricor Therapeutics (US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
    Table 105. Capricor Therapeutics (US) Recent Development
    Table 106. Exiqon A/S (Denmark) Company Details
    Table 107. Exiqon A/S (Denmark) Business Overview
    Table 108. Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Product
    Table 109. Exiqon A/S (Denmark) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
    Table 110. Exiqon A/S (Denmark) Recent Development
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Exosome Diagnostics and Therapeutics Market Share by Type: 2020 VS 2027
    Figure 2. Instrument Features
    Figure 3. Reagent Features
    Figure 4. Software Features
    Figure 5. Global Exosome Diagnostics and Therapeutics Market Share by Application: 2020 VS 2027
    Figure 6. Diagnostic Case Studies
    Figure 7. Therapeutic Case Studies
    Figure 8. Exosome Diagnostics and Therapeutics Report Years Considered
    Figure 9. Global Exosome Diagnostics and Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Exosome Diagnostics and Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Exosome Diagnostics and Therapeutics Market Share by Regions: 2020 VS 2027
    Figure 12. Global Exosome Diagnostics and Therapeutics Market Share by Regions (2022-2027)
    Figure 13. Global Exosome Diagnostics and Therapeutics Market Share by Players in 2020
    Figure 14. Global Top Exosome Diagnostics and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Exosome Diagnostics and Therapeutics as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Exosome Diagnostics and Therapeutics Revenue in 2020
    Figure 16. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Type (2016-2021)
    Figure 17. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Type (2022-2027)
    Figure 18. North America Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Exosome Diagnostics and Therapeutics Market Share by Type (2016-2027)
    Figure 20. North America Exosome Diagnostics and Therapeutics Market Share by Application (2016-2027)
    Figure 21. North America Exosome Diagnostics and Therapeutics Market Share by Country (2016-2027)
    Figure 22. United States Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Exosome Diagnostics and Therapeutics Market Share by Type (2016-2027)
    Figure 26. Europe Exosome Diagnostics and Therapeutics Market Share by Application (2016-2027)
    Figure 27. Europe Exosome Diagnostics and Therapeutics Market Share by Country (2016-2027)
    Figure 28. Germany Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Exosome Diagnostics and Therapeutics Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Exosome Diagnostics and Therapeutics Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Exosome Diagnostics and Therapeutics Market Share by Region (2016-2027)
    Figure 38. China Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Exosome Diagnostics and Therapeutics Market Share by Type (2016-2027)
    Figure 46. Latin America Exosome Diagnostics and Therapeutics Market Share by Application (2016-2027)
    Figure 47. Latin America Exosome Diagnostics and Therapeutics Market Share by Country (2016-2027)
    Figure 48. Mexico Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Exosome Diagnostics and Therapeutics Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Exosome Diagnostics and Therapeutics Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Exosome Diagnostics and Therapeutics Market Share by Country (2016-2027)
    Figure 54. Turkey Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Aethlon Medical(US) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2016-2021)
    Figure 58. Exosome Diagnostics(US) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2016-2021)
    Figure 59. NanoSomix Inc.(US) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2016-2021)
    Figure 60. Thermo Fisher Scientific (US) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2016-2021)
    Figure 61. Malvern Instruments (UK) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2016-2021)
    Figure 62. System Biosciences(US) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2016-2021)
    Figure 63. NX Pharmagen (US) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2016-2021)
    Figure 64. Sistemic Inc(UK) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2016-2021)
    Figure 65. Capricor Therapeutics (US) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2016-2021)
    Figure 66. Exiqon A/S (Denmark) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2016-2021)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Aethlon Medical(US)
Exosome Diagnostics(US)
NanoSomix Inc.(US)
Thermo Fisher Scientific (US)
Malvern Instruments (UK)
System Biosciences(US)
NX Pharmagen (US)
Sistemic Inc(UK)
Capricor Therapeutics (US)
Exiqon A/S (Denmark)
Frequently Asked Questions
Exosome Diagnostics and Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Exosome Diagnostics and Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Exosome Diagnostics and Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports